A company that specializes in EHF (Electrospun Healing Fiber) technology for wound healing and skin regeneration, Nanomedic Technologies, is glad to announce the outcome of a new peer-reviewed analysis that shows promising outcomes when its Spincare system is used to treat superficial and partial wounds and burns.
Published in the Annals of Burns and Fire Disasters, the official publication of the Euro-Mediterranean Council for Burns and Fire Disasters and the European Burns Association, the prospective single-centre observational trial revealed that the maximum range of motion possessed by the Spincare Polymer Nanofibrous Dressing (PND) made it suitable for covering all types of wounds and adheres well to wound surfaces throughout the time it needs to heal.
“Because electrospinning technology has become increasingly important recently, there’s this eagerness in us to explore the potential use of the new Spincare system to treat a range of wounds and burns. We discovered that the system is easy to use as well as delighted to see that the nanofiber layer is applicable to several cases, including after enzymatic debridement in burn wounds delivering results that are promising for the treatment of superficial to thick wounds.” Said the lead author of the study at the Cologne-Merheim Medical Centre, Dr. Alexandra Schulz.
Rambam Health Care Campus is the first hospital in Israel to formally adopt the system for its trauma department. The CEO added, “We are delighted to support Rambam Hospital in its effort to provide patients with the most advanced solutions for wound healing and skin regeneration and look forward to helping other facilities bring this important healthcare technology to their patients and physicians as well,
The clinical study with a duration of four months analyzed the treatment outcomes of 10 patients aged 19 to 76 years. The treated subjects suffered from superficial to partially thick wounds, including donor site burns with split-thickness. The things that were assessed included the treatments, procedures, location of the injury, treatment times, and ease of use. The researchers promptly mastered the use of the Spincare System, and the PND was used between the day of the injury and up to 21 days after the injury. There was no sign of the injury or any adverse effects in any of the treated cases. The overall results showed that Spincare PND is a patient-friendly temporary epidermal layer adapted for the treatment of superficial to partially thick wounds, including burns too.
The chief executive officer of Nanomedic, Dr. Chen Barak, commented: “ The study results evaluating the efficacy and ease of use of Spincare on human donor sites and burn wounds have considerably encouraged us. This solution we have provided offers an easy one-time application for improved treatment of wounds while giving patients the opportunity to quickly return to their daily activities, with improved mobility and extraordinary scarring and healing. We are greatly satisfied that our device has been tested by the Cologne-Merheim Medical Centre, and are working on more clinical studies with medical facilities all around the world.”
In the next few months, the next steps of the assessment that will include treating superficial to partial-thickness burns with PND on a larger scale will be presented with an emphasis placed on the long-term scarring as well as the healing time.
